nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECT
|
Rieckmann, Peter |
|
|
39 |
6 |
p. 2749-2760 |
artikel |
2 |
Advances in Clinical Cardiology 2021: A Summary of Key Clinical Trials
|
Savage, Patrick |
|
|
39 |
6 |
p. 2398-2437 |
artikel |
3 |
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types
|
Torres, Aracelis Z. |
|
|
39 |
6 |
p. 2831-2849 |
artikel |
4 |
A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma
|
Brittain, Dominic |
|
|
39 |
6 |
p. 2365-2378 |
artikel |
5 |
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate Cancer
|
Danese, Mark D. |
|
|
39 |
6 |
p. 2778-2795 |
artikel |
6 |
Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials
|
van der Horst-Bruinsma, Irene E. |
|
|
39 |
6 |
p. 2806-2819 |
artikel |
7 |
Changes in Refractive Error Under COVID-19: A 3-Year Follow-up Study
|
Yang, Xiaoyan |
|
|
39 |
6 |
p. 2999-3010 |
artikel |
8 |
Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK
|
Gillmore, Julian D. |
|
|
39 |
6 |
p. 2292-2301 |
artikel |
9 |
Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China
|
Zhang, Peng |
|
|
39 |
6 |
p. 2920-2931 |
artikel |
10 |
Correction to: Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study
|
Dalén, Johan |
|
|
39 |
6 |
p. 2487-2488 |
artikel |
11 |
Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
|
Harrow, Brooke |
|
|
39 |
6 |
p. 3059-3060 |
artikel |
12 |
Correction to: The Economic Burden of Insulin Injection-Induced Lipohypertrophy. Role of Education: The ISTERP-3 Study
|
Gentile, Sandro |
|
|
39 |
6 |
p. 3058 |
artikel |
13 |
Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China
|
Xiao, Dunming |
|
|
39 |
6 |
p. 2971-2983 |
artikel |
14 |
Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective
|
Fischer, Barbara |
|
|
39 |
6 |
p. 2717-2730 |
artikel |
15 |
Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records
|
Iff, Joel |
|
|
39 |
6 |
p. 2906-2919 |
artikel |
16 |
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial
|
Garweg, Justus G. |
|
|
39 |
6 |
p. 2701-2716 |
artikel |
17 |
Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database
|
Mease, Philip J. |
|
|
39 |
6 |
p. 2932-2945 |
artikel |
18 |
Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial
|
Dreher, Michael |
|
|
39 |
6 |
p. 3011-3018 |
artikel |
19 |
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup
|
Okada, Annabelle A. |
|
|
39 |
6 |
p. 2984-2998 |
artikel |
20 |
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review
|
Jensterle, Mojca |
|
|
39 |
6 |
p. 2452-2467 |
artikel |
21 |
Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM
|
Kawaguchi, Yuji |
|
|
39 |
6 |
p. 2688-2700 |
artikel |
22 |
Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study
|
Pu, Yeong-Shiau |
|
|
39 |
6 |
p. 2641-2656 |
artikel |
23 |
Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database
|
Weil, Clara |
|
|
39 |
6 |
p. 2502-2514 |
artikel |
24 |
Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study
|
Dalén, Johan |
|
|
39 |
6 |
p. 2468-2486 |
artikel |
25 |
Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer
|
Simmons, Daniel |
|
|
39 |
6 |
p. 2544-2561 |
artikel |
26 |
High Expression of C8orf76 Is an Independent Predictive Factor of Poor Prognosis in Patients with Breast Cancer
|
Wang, Yitong |
|
|
39 |
6 |
p. 2946-2960 |
artikel |
27 |
“I Can’t Take off My Shirt or Do My Own Hair”—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP)
|
Markowitz, Jessica T. |
|
|
39 |
6 |
p. 2796-2805 |
artikel |
28 |
Improving Care in Eosinophil-Associated Diseases: A Charter
|
Jackson, David J. |
|
|
39 |
6 |
p. 2323-2341 |
artikel |
29 |
Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study
|
Schubert, Stefan |
|
|
39 |
6 |
p. 2889-2905 |
artikel |
30 |
Iron Deficiency in Women’s Health: New Insights into Diagnosis and Treatment
|
Moisidis-Tesch, Christina M. |
|
|
39 |
6 |
p. 2438-2451 |
artikel |
31 |
Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases
|
Al Dubayee, Mohammed |
|
|
39 |
6 |
p. 3042-3057 |
artikel |
32 |
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
|
Chabra, Sanjay |
|
|
39 |
6 |
p. 2862-2872 |
artikel |
33 |
Menstrual Symptoms, Health-Related Quality of Life, and Work Productivity in Japanese Women with Dysmenorrhea Receiving Different Treatments: Prospective Observational Study
|
Yoshino, Osamu |
|
|
39 |
6 |
p. 2562-2577 |
artikel |
34 |
Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn’s Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons
|
Williams, Paul |
|
|
39 |
6 |
p. 2761-2777 |
artikel |
35 |
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study
|
Smith, Denis |
|
|
39 |
6 |
p. 2731-2748 |
artikel |
36 |
Occurrence and Prognosis of Secondary Lung Cancer in Patients with Primary Nasal Cavity and Sinus Squamous Cell Carcinoma
|
Feng, Jing |
|
|
39 |
6 |
p. 2533-2543 |
artikel |
37 |
One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study
|
Duval, Xavier |
|
|
39 |
6 |
p. 3031-3041 |
artikel |
38 |
Pembrolizumab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A Cost-Effectiveness Analysis
|
Zhu, Youwen |
|
|
39 |
6 |
p. 2614-2629 |
artikel |
39 |
Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
|
Schreiber, Stefan |
|
|
39 |
6 |
p. 2342-2364 |
artikel |
40 |
Proposal for a New Protocol for the Management of Immune Thrombocytopenia (ITP)
|
González-López, Tomás José |
|
|
39 |
6 |
p. 2287-2291 |
artikel |
41 |
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective
|
Bhutani, Mohit |
|
|
39 |
6 |
p. 2302-2322 |
artikel |
42 |
Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer
|
Satake, Hironaga |
|
|
39 |
6 |
p. 2596-2613 |
artikel |
43 |
Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents
|
Hafron, Jason M. |
|
|
39 |
6 |
p. 2515-2532 |
artikel |
44 |
Real-World Treatment Patterns After CD19-Directed CAR T Cell Therapy Among Patients with Diffuse Large B Cell Lymphoma
|
Jalbert, Jessica J. |
|
|
39 |
6 |
p. 2630-2640 |
artikel |
45 |
Recommendations from a Working Group on Obesity Care Competencies for Healthcare Education in the UK: A Report by the Steering Committee
|
Capehorn, Matthew S. |
|
|
39 |
6 |
p. 3019-3030 |
artikel |
46 |
Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?
|
Papachristou, Stella |
|
|
39 |
6 |
p. 2283-2286 |
artikel |
47 |
Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison
|
Cordoba, Raul |
|
|
39 |
6 |
p. 2668-2687 |
artikel |
48 |
The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study
|
Terauchi, Yasuo |
|
|
39 |
6 |
p. 2873-2888 |
artikel |
49 |
The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours
|
López, Fernando |
|
|
39 |
6 |
p. 2379-2397 |
artikel |
50 |
Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey
|
Armstrong, April |
|
|
39 |
6 |
p. 2657-2667 |
artikel |
51 |
Treatment Patterns Among Patients with Bipolar Disorder in the United States: A Retrospective Claims Database Analysis
|
Jain, Rakesh |
|
|
39 |
6 |
p. 2578-2595 |
artikel |
52 |
Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study
|
Wang, Xin |
|
|
39 |
6 |
p. 2820-2830 |
artikel |
53 |
Use of Perindopril Arginine/Indapamide/Amlodipine in the Management of Hypertension in Two Sub-Saharan African Island Countries of Madagascar and Mauritius
|
Mbanya, Armand |
|
|
39 |
6 |
p. 2850-2861 |
artikel |
54 |
What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine
|
Müderrisoglu, A. Elif |
|
|
39 |
6 |
p. 2489-2501 |
artikel |
55 |
17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial
|
Luo, Chengyu |
|
|
39 |
6 |
p. 2961-2970 |
artikel |